Warren Paroly is an Oncology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 6 publications with 460 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3925 Waring Rd Ste C
Oceanside, CA 920564459
Telephone
760-758-5770Registry record last updated 8 Jul 2007.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- ABBVIE INC.Program year20255 payments
- Merck Sharp & Dohme LLCProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
94.5%Erythropoiesis-stimulating Agent94.5%Darbepoetin alfa100%Retacrit0%Part D + Part B<11 patientsMusculoskeletal
4.9%RANK Ligand Inhibitor4.9%Denosumab100%Part B, office-administered≥14 patientsCancer & immunology
0.4%Kinase inhibitor0.1%Imbruvica45%Brukinsa29%Calquence26%Part D<11 patientsAromatase Inhibitor0.1%Exemestane52%Letrozole48%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Randomized double-blind phase 2 study evaluating sameday vs next-day administration of pegfilgrastim with docetaxel, doxorubicin, and cyclophosphamide (tac) in women with early stage and advanced breast cancer
Breast Cancer Research and Treatment
2004 - Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity.
PubMed
1980
Similar KOLs
Other experts from the same institution or the same specialty.
Tanush Gupta, MD
Dartmouth–Hitchcock Medical Center
Jack Cronenwett, MD
Dartmouth–Hitchcock Medical Center
David Malenka, MD
Dartmouth–Hitchcock Medical Center
Robert Santulli, MD
Dartmouth–Hitchcock Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”